Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Larsen

Showing results (951-960 of 982) with videos related to

Pageof 99
Sort By:
Journal of Biomolecular Screening|August 17, 2011
Complementary cell-based high-throughput screens identify novel modulators of the unfolded protein responseAndrew M Fribley, Patricia G Cruz, Justin R Miller, et al.
Plos One|July 30, 2014
KCNMA1 encoded cardiac BK channels afford protection against ischemia-reperfusion injuryEwa Soltysinska, Bo Hjorth Bentzen, Maria Barthmes, et al.
Medrxiv : the Preprint Server for Health Sciences|June 2, 2021
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19Ravindra Ganesh, Colin Pawlowski, John C O'Horo, et al.
Nature Cell Biology|August 17, 2017
NFIA co-localizes with PPARγ and transcriptionally controls the brown fat gene programYuta Hiraike, Hironori Waki, Jing Yu, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass SurgeryTina Jorsal, Nicolai J Wewer Albrechtsen, Marie M Christensen, et al.
The Journal of Infectious Diseases|July 19, 2021
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, et al.
The Journal of Clinical Investigation|August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.
Breast Cancer Research : BCR|January 9, 2024
Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variantInes Block, Àngels Mateu-Regué, Thi Tuyet Nhu Do, et al.
Clinical Genetics|July 23, 2021
Epileptic encephalopathy caused by ARV1 deficiency: Refinement of the genotype-phenotype spectrum and functional impact on GPI-anchored proteinsSmrithi Salian, Marcello Scala, Thi Tuyet Mai Nguyen, et al.
Molecular Metabolism|April 5, 2025
Excessive exercise elicits poly (ADP-ribose) Polymerase-1 activation and global protein PARylation driving muscle dysfunction and performance impairmentBarbara M Crisol, Matheus B Rocha, Beatriz Franco, et al.
Pageof 99

Showing results (951-960 of 982) with videos related to

Sort By:
Pageof 99
Journal of Biomolecular Screening|August 17, 2011
Complementary cell-based high-throughput screens identify novel modulators of the unfolded protein responseAndrew M Fribley, Patricia G Cruz, Justin R Miller, et al.
Plos One|July 30, 2014
KCNMA1 encoded cardiac BK channels afford protection against ischemia-reperfusion injuryEwa Soltysinska, Bo Hjorth Bentzen, Maria Barthmes, et al.
Medrxiv : the Preprint Server for Health Sciences|June 2, 2021
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19Ravindra Ganesh, Colin Pawlowski, John C O'Horo, et al.
Nature Cell Biology|August 17, 2017
NFIA co-localizes with PPARγ and transcriptionally controls the brown fat gene programYuta Hiraike, Hironori Waki, Jing Yu, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass SurgeryTina Jorsal, Nicolai J Wewer Albrechtsen, Marie M Christensen, et al.
The Journal of Infectious Diseases|July 19, 2021
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, et al.
The Journal of Clinical Investigation|August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.
Breast Cancer Research : BCR|January 9, 2024
Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variantInes Block, Àngels Mateu-Regué, Thi Tuyet Nhu Do, et al.
Clinical Genetics|July 23, 2021
Epileptic encephalopathy caused by ARV1 deficiency: Refinement of the genotype-phenotype spectrum and functional impact on GPI-anchored proteinsSmrithi Salian, Marcello Scala, Thi Tuyet Mai Nguyen, et al.
Molecular Metabolism|April 5, 2025
Excessive exercise elicits poly (ADP-ribose) Polymerase-1 activation and global protein PARylation driving muscle dysfunction and performance impairmentBarbara M Crisol, Matheus B Rocha, Beatriz Franco, et al.
Pageof 99